News I Sino Bioengineering

Biosimilar facility development continues to confront a prevalent and critical industry challenge: delivering fully cGMP-compliant, high-throughput biomanufacturing infrastructure un……

At the cutting edge of biomedicine, liposomes have emerged as star delivery vehicles in the pharmaceutical industry, owing to their unique biomimetic architecture and superior drug ……

Regulatory approval has long stood as one of the most challenging, high-stakes and unpredictable bottlenecks in the entire development lifecycle of new pharmaceutical, biotech and li……

The pharmaceutical industry is defined by rigorous regulatory requirements, intense time-to-market pressure, and zero-tolerance standards for facility quality and compliance. For fas……

The pharmaceutical industry differs from other industrial sectors in its strict adherence to process rationality and regulatory compliance. While conventional engineering prioritizes……

In downstream biopharmaceutical processes, depth filtration features high dirt-holding capacity and multi-mechanism retention (mechanical interception/size exclusion, electrostatic ……

We offer end-to-end full-lifecycle consulting and planning services for cGMP pharmaceutical and bioprocessing facilities, covering every stage from pre-investment evaluation to post……

In recent years, mRNA technology has emerged as a transformative breakthrough in the biopharmaceutical industry. Characterized by rapid research and development cycles, flexible pro……

In research and industrial production of protein science, protein separation, purification and concentration constitute pivotal steps governing experimental outcomes. As a core sepa……

Against the explosive growth of gene therapies and mRNA vaccines in biopharmaceuticals, plasmid DNA (pDNA) as a core raw material demands rigorous optimization of its manufacturing ……

At the cutting edge of biopharmaceuticals, gene therapies and novel vaccines (e.g., mRNA vaccines, viral vector vaccines) are transforming humanity’s arsenal against diseases at an ……

In the history of biopharmaceutical advancement, the rise of mRNA vaccines represents an unparalleled revolution in speed and manufacturing efficiency. Unlike conventional vaccines,……

As one of the most widely adopted nanomedicine delivery systems to date, liposomes, first discovered in the 1960s, have been extensively deployed in anti-tumor therapeutics, nucleic……

In the biopharmaceutical industry, fusion proteins stand out as promising therapeutic biologics, as they integrate two or more distinct functional proteins into a single molecular c……

In the downstream bioprocess of biopharmaceuticals, depth filtration stands as the primary clarification method for cell culture and fermentation broths, owing to its high dirt-hold……

With the rapid advancement of molecular biology and genetic engineering, technologies including mRNA vaccines, siRNA therapeutics, ASO drugs, gene editing, cell therapy, and in vivo……